CytoDyn Inc (QB) (CYDY) Quote

I posted a link to an article about that in the post t which you're replying. Evidently you didn't bother to read it.

Doesn't matter what you think. Remember you don't need to know anything about pharma. Well, you don't.

https://dailynewscycle.com/rfk-jr-unveils-plan-to-curb-big-pharmas-influence-on-u-s-healthcare/

You might want to read this and reconsider your post.

“You guys are collaborating with the pharmaceutical industry to lie to the American public about the efficacy and safety of these products,” Kennedy said. “We are going to sue you both civilly for damages and criminally for fraud.”

Get ready to rumble. $CYDY$ 2024-25

Bobby Jr. is going to trim and spin till BP and corrupt FDA personnel are tossed off the merry-go-round and sent flying and flopping like dizzy sick birds on a hot rock.

I really don't think he'll have much luck with that. He seems to be focused on anti-vaxxer propaganda. And things like raw milk that only serious cheese fanatics care about. But it also seems he doesn't care for the stranglehold the healthcare industry has on congress.

This was from early this morning:

RFK Jr vow to purge FDA sets up collision with Big Pharma

https://www.reuters.com/business/healthcare-pharmaceuticals/rfk-jr-vow-purge-fda-sets-up-collision-with-big-pharma-2024-11-15/

But the pharmas always fight back, and they have tons of money to spend on that.

More of a chance Jay gets deported to Iran than Merck even sniffing this steaming pile of dung, which by the way, since you are speaking of patents, lost its foundational patents.

Bobby Jr. is going to trim and spin till BP and corrupt FDA personnel are tossed off the merry-go-round and sent flying and flopping like dizzy sick birds on a hot rock. Repercussions are going to cause some quantum shifts that propel overlooked highly potential drug candidates into the limelight. Take for example Merck's keytruda for cancer. They are on a buying spree...and they got the bucks...to shore up their keyturda which only works in perhaps 40% of the cases. Their patent will expire in a few years and much better drugs are in trials already outperforming it. So will they ...and others...be eyeballing leronlimab along with other promising candidates? You bet they will.
CytoDyn will break out once the public catches on and that will come after a block buster PR. I wonder what company Dr. Jay is liking most for collaboration as mentioned a few times. Yes docj, something is brewing with the Tanya connection stepping in. Things could get really interesting really quick .

Buying.
ps. God rest his soul, Fernando Venezuela was a great ball player. A shame he didn't have access to leronlimab under Compassionate Use. Maybe Bobbie can so something about such cases. We saved Eraps life and others so why not? I know the company, many companies for that matter, have to tippy toe around the FDA. Maybe those days will be over in the near future. Praying.

$CYDY$ 2024-25
https://petermcculloughmd.substack.com/p/breaking-news-robert-f-kennedy-jr

Something Leronlimab may have an indication for in the future:

Fernando Valenzuela’s cause of death has been determined after the Dodgers legend died last month at the age of 63.

According to his death certificate, the broadcaster and former pitched died due to decompensated alcoholic cirrhosis and nonalcoholic steatohepatitis cirrhosis.

It looks like Tanya Urbach’s current employer, Eagle Bay Advisors may have purchased 162,000 shares of Cytodyn per a 13F-HR form being filed.

Stock market: all time high. Bitcoin: all time high. This junk: all time low. Lolllllllllll moranssss!!!!

What would the number be if Scott Kelly is forced to tell under oath how many partners were "lined up" whenever he'd be on those video calls hinting about partners? Who knows, maybe one day he will be forced to tell once the class actions lawsuits arrive after Nadir is convicted.

These are the same folks that said CYDY had multi partners lined up just waiting for the hold to be lifted. As stated several times--ANYONE with reality KNOWS #1-- there were no partners "lined up" before the hold (s) #2--there was ZERO data/trial run during the hold. So what would line up any partner during a hold?? Just nonsense. This is just part of the phony narrative constantly being pumped @ livimmune
The latest (that will soon be shown to be nonsense) is how the second draining of the swamp will produce all these miracles across multiple "concerns"

There will soon be a narrative about record U S oil production (never mind that is NOW not in a few months )
There will soon be a narrative about some new beautiful wall that Mexico is paying for (again)
There will soon be narrative about replace obamacare (again)
Drug approvals without trials
All while promoting putin/xi/rocketman etc

All nonsense--but swallowed WHOLE by the livimmune crowd. Keep in mind THEY were also saying what a great job nodder was doing and that crowd along with ihang mods were and are still making excuses for their cult leaders. Q--ump--nodder--etc

Not sure why you think total replacement of fda will help cydy. Only clinical tests in cancer will do that

Told you all this was coming for over a year now. Get ready, FDA is going under the knife for a facelift. Long long long overdue.
RFK Jr. Wants To Remove Entire Departments In FDA, Tells Corrupt Employees To “Pack Your Bags”
“I can get the corruption out of the agencies,” he said.

“That’s what I’ve been doing for 40 years. I’ve sued all those agencies. I have a Ph.D. in corporate corruption,” he added.
https://wltreport.com/2024/11/08/rfk-jr-wants-remove-entire-departments-fda-tells/?_bhlid=fdbd1bb4ccda9d97118fb0f3a2276fb80912327a
Coming together finally. We will have an FDA that will follow their mandate and policies as written. The revolving door between BP and the FDA
will go from a locked goose step to a chicken scratch. Pigeons will fly the coup. Dr. J already made great inroads and now with our latest additions to
the team that have a mountain of experience in dealing with new products and the FDA. Leronlimab already showing up as posted by docj. We are on the cusp of a new awakening for leronlimab as CCR5 is coming on strong.



"Companies in the CCR5 market are focusing on developing new drugs, such as CCR5 antagonists, to maintain a competitive edge. CCR5 antagonists are medications that block the CCR5 receptor on immune cells, preventing certain pathogens such as HIV from binding and entering these cells, thereby inhibiting infection and influencing immune responses. For instance, in February 2024, CytoDyn Inc., a US-based biotechnology firm, announced that the U.S. Food and Drug Administration (FDA) had lifted the clinical hold on leronlimab, a CCR5 antagonist also known as PRO 140. This approva[color=red]l allows CytoDyn to proceed with its planned clinical trial to evaluate leronlimab's effects on chronic inflammation. Leronlimab shows potential for treating various health conditions, including HIV and cancer, due to its ability to target multiple diseases.[/color" Per docj's posting from Globe Wire


Yes, a brave new world is rushing in. Get ready for it. Aldous surely must have been buddies with Edgar Cayce and Jean Dixon.
$CYDY$ 2024-25

Mentions CYDY (CC chemokine receptor type 5 market)
https://www.globenewswire.com/news-release/2024/11/07/2976822/0/en/CC-Chemokine-Receptor-Type-5-Market-Research-Report-2024.html

Instead of monkey viral outbreak studies--the monkeys have decided to breakout

Dr Sacha keep those cages locked

https://apnews.com/article/monkeys-escape-alpha-genesis-south-carolina-66a78279a7abe57c5f8fd0953359368a

Fibrosis split from MASH at some point on the pipeline chart:

https://www.cytodyn.com/pipeline

https://www.targetedonc.com/view/fda-clears-phase-2-trial-of-leronlimab-for-microsatellite-stable-crc

you are correct, but I answered your statement already in my last message my way.

You been took by a snake oil salesman and you still can't admit it to yourself

Promise, promises were going on for too long a time. Promises of all kinds never impressed the stock market.

When we are told to wait 1 week, 6 weeks or even until mid year 2025 for anything potential, even a little bit that stock market will be aware of, that Leronlimab exists, what should we do to calm our angcyety ?

What can we do about, to calm our nerves, to go on and on ?

DJIA up 1300 (3.07%) and rising. What gives? Perhaps the new health czar is going to make some bad ass changes to our health system. Sure would like to see those loudmouth FDA cronies who negated CytoDyn get the boot. Nader screwed up but so did the FDA and that is but one of his hole cards. Don't worry, it will all be whitewashed and CytoDyn's leronlimab is on track to be recognized for it's overall health benefits and safey for many indications. One day this will be a Nader three finger stock and it may well be my grandkids reap the big windfall. However, I do expect to be buying a greater quality bourbon among other goodies. Watch.
Thanks for the cheapies fellas. Taking full advantage of your actions.

RFK Jr. is just what the doctor ordered as Wall Street is now confirming!!!
Our jab competition Fuzzy Fizzle Fizer pfe is getting slammed again today, down hard. They know Burla is going to trial around the world.

Now more than ever. $$$CYDY$$$ 2024-2025
Dr. Jay and Tanya and Team, thanks for the turn around.

LOL.....It would be much smarter of you to gamble in Vegas than bet on this stock. And you can get a free drink!
Take that CYDY money, walk to the first Craps table you see, once the point is set, put the next bet on Don't Come.....take your winnings from there, and once point is made, move it all to Come....take your winnings and forget you even thought about throwing it away here.

Well he is charged with the lowest of the low hanging fruit. Prob a wrist slap from some plea deal. Just sad

The $ 2000.-__ refund I saved to invest in CYDY, I save for new year, when I go to Las Vegas and stay there for a week and when I come back I check on cydy, When I see ppromises for the year 2025, I wait till mid February to sell all my shares for a very low priice.

Oh Nader will be shouting out "they do fantastic job!" again, but this time about the DOJ after he's convicted and lead away in cuffs.

Are the Bollinger bands pinching durrrrr

Wall Street seems absolutely giddy over the news.

Every one is getting paid. Life is beautiful, as long as Leronlimab stays out of public circulation.

Just my opinion

CytoDyn is working with a team of experts to resume the exploration of Triple-Negative Breast Cancer

So NOT "dr" nodder and NOT dr kelly. No more micky mulholland and no more weed/wine. No more CRO kickbacks/fraud

No more airline partners and broken fax machines. No more using wrong SOC for BTD.

No more mistaking tropism for receptor occupancy. No more lack of dosing studies. No more BLA lies. No more stealing of shareholder equity. No more mother in law stories . No more $ 100 million + lawsuit manna stories. No more NDA made up crappola. No more skirting SEC regs. No more "they do fantastic job"

Tanya doing great job. Please stock ar 12c. You guys that support her are delusional. Clinical trial that has no clinic .

Excerpt taken from the September Shareholder Letter:

In addition to CRC, CytoDyn is investigating the role for leronlimab in two other oncology indications via strategic and low-cost research and development opportunities, and in collaboration with several reputable institutions. I am pleased to announce that CytoDyn is working with a team of experts to resume the exploration of Triple-Negative Breast Cancer (“TNBC”), including colleagues from the University of Hawaii Cancer Center, MD Anderson Cancer Center, and the Pennsylvania Cancer and Regenerative Medicine Research Center. We will be working with this team in the coming months to design and conduct a preclinical TNBC study that will aim to confirm the mechanism of action of leronlimab in oncology and address the question of potential synergies with both antibody-drug conjugates and immune checkpoint inhibitors. The Company intends to use this preclinical study to form the basis for a potential partnership and better inform the design of a follow-up clinical study in patients with metastatic TNBC.

New SAB member:
Clinton Yam, MD, MS
Dr. Clinton Yam is an Associate Professor with dual appointments in the Departments of Breast Medical Oncology and Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center. Dr. Yam is leader of the triple-negative breast cancer (TNBC) working group and Director of Team Science and Innovation in the Department of Breast Medical Oncology at MD Anderson. He is the principal investigator for several industry sponsored and investigator initiated clinical trials. Dr. Yam is very much involved in multidisciplinary efforts aimed at understanding the biology of TNBC to inform the design of innovative clinical trials to improve outcomes for patients with TNBC.

Who says they don't? We'll find out in due time. The trial does't start until early next year.

Why announce zrial if they dont have a site and a partner

They are on their timeline--not anyone else. As we ----->>>> toward holidays--expect delays (trademark)

All shareholders are paying

They anncd their intended CRO

Site recruitment--then PIs at each etc take time. You might want Mayo/they might not feel mutual. When "it" ( RCT) is shown @ clin trials .gov many of those ??s will be answered.

Only people confused are longs watching this trash end red again lol

I will wait until mid december to let them give details. However,its unusual to announce a clinica trial that you will be enrolling patients and not say who you are teaming up with,where it is,who is paying for it. Hopefully ,everything will go smoothly.

Tanya has done a great job steering CYDY to calm waters. I do think she may have been too strict directing Tyler along the way PR wise but that is just my opinion. She isn't going anywhere until Dr NP's trial is over and any lawsuit she is named in is dealt with.

If it’s bothering you that much, call them and ask them, the details are not out yet, the approval is, and about right on time according to Dr L’s timeline

It takes time for the info to be posted on the clinical trials site once the company finalizes the details. As per the PR, they are having a trial kick off meeting in late November. Could very well be some final trial planning decisions at that point so revisions are possible.

Exactly,no details. Why

Details not posted on the clinical trials website yet.

As far as we know Cytodyn is paying for the phase 2 trial. If the results pan out, there is a great chance there will be multiple BP companies interested in partnering for a phase 3.

Well,i am confused. Since your not ,please answer my questions. Where are trials,how much are trials,who is paying for trials,what drs are working with cydy in these trials,how long are trials. Thank you for helping me

You seem really confused

Where are these trials being held? Is there a partner. How about $$$$

Who is paying for these trials? How much are trials?

has received clearance from the FDA to commence its Phase II oncology trial. The study will evaluate the efficacy of leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer (“CRC”).

This milestone reflects the continued positive development of the Company’s improved relationship with the FDA. Clearance for the Phase II oncology trial was achieved following productive feedback sessions with the FDA over the past few months and the submission of a final study protocol to the FDA in September 2024. As previously announced, the trial will be conducted in partnership with Syneos Health. A trial kickoff meeting has been set for late November 2024 and patient enrollment will begin in early 2025.

Skeleton Crew strikes again!!! Way to go TEAM Leronlimab.
$CYDY$ 2024

I do believe I predicted this by Halloween or at latest Turkey Day. I am so Thanks Giving!!
Buying some more!!

Lollll

"They lack efficient training in every FSP I have been on. They hire individuals that aren’t qualified so they can pay them less. They hire managers that haven’t been in the role they are managing and they can’t offer assistance. They don’t look at how processes could be improved to reduce waste and variation. They really need to work on improving their training and processes."

Lol read the reviews of syneos health lolllll

"They’re outsourcing everything. My reports are reviewed by someone in Eastern Europe whose sole job it is to review reports."

Definitely happy to see this long overdue news. Thanks for posting!

CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial

https://www.cytodyn.com/newsroom/press-releases/detail/631/cytodyn-announces-fda-clearance-of-its-phase-ii-oncology

VANCOUVER, Washington, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that it has received clearance from the FDA to commence its Phase II oncology trial. The study will evaluate the efficacy of leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer (“CRC”).

This milestone reflects the continued positive development of the Company’s improved relationship with the FDA. Clearance for the Phase II oncology trial was achieved following productive feedback sessions with the FDA over the past few months and the submission of a final study protocol to the FDA in September 2024. As previously announced, the trial will be conducted in partnership with Syneos Health. A trial kickoff meeting has been set for late November 2024 and patient enrollment will begin in early 2025.

“We have appreciated the opportunity to work constructively with the FDA on the review and finalization of our CRC protocol,” said Dr. Jacob Lalezari CEO. “With the agency’s input and our partnership with Syneos Health, we are well positioned to advance our clinical evaluation of leronlimab for oncology and make real strides towards developing the treatment paths of tomorrow.”